NOT_YET_RECRUITING
I'm interested ...!!
Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients
The purpose of this trial is to study the effectiveness of the AprictyRxTM care service to improve treatment outcomes of ethnic/racial minority N.S.C.L.C. patients receiving standard of care immunotherapy, and reduce the frequency of healthcare system interactions.
Conditions:
🦠 Non Small Cell Lung Cancer
🗓️ Study Start (Actual) April 2023
🗓️ Primary Completion (Estimated) August 2025
✅ Study Completion (Estimated) August 2025
👥 Enrollment (Estimated) 280
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age≥ 18 years
    • * Confirmed NSCLC diagnosis
    • * Prescribed treatment with immune-checkpoint inhibitor, including in combination with chemotherapy
    • * Ability to understand and the willingness to sign a written informed consent document
    • * Self-identification as a member of an ethnic minority or underserved population.

    Exclusion Criteria:

    • * An individual with presence of any medical, psychological, or social condition that, in the opinion of the investigator would preclude participation in this study.
    • * Patients enrolled in other interventional clinical trials at the time of screening will be excluded.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 30 March 2023
  • First Submitted that Met QC Criteria 31 March 2023
  • First Posted 13 April 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 31 March 2023
  • Last Update Posted 13 April 2023
  • Last Verified March 2023
I'm interested ...!!